A TAME Attempt to Slow Aging Part 4: Mixed Messages on Metformin and the Mind
Metformin has been proposed as an “anti-aging drug,” and a major clinical trial is about to get underway to test the idea.
Michael Rae January 10, 2023
Menu
The SENSible Blog discusses the development of rejuvenation biotechnology around the world: progress being made in the field of longevity, the design of medical therapies to cure, reverse and prevent the diseases and disabilities of aging, and much more.
Our content is a blend of popular interest articles – labelled “Easy Reads”, and designed to require no specific background knowledge – as well as more detailed scientific commentaries, labelled as “In-Depth” and aimed towards readers with some grounding in the biological/medical sciences.
Metformin has been proposed as an “anti-aging drug,” and a major clinical trial is about to get underway to test the idea.
A supporter asks about the investigative report in Science magazine that suggests the critical study identifying beta-amyloid oligomers as the key actors in Alzheimer’s disease may have been based on fraudulent data.
Metformin has been proposed as an “anti-aging drug,” and a major clinical trial is about to get underway to test the idea.
A supporter asks about how the central MitoSENS strategy can be delivered to our cells.
Metformin has been proposed as an “anti-aging drug,” and a major clinical trial is about to get underway to test the idea.
A supporter asks if cellular reprogramming turns an old person’s cells young again,can’t we fix aging by just reprogramming a person’s old cells with reprogramming factors?
Sign up to stay informed about the latest news and opportunities with SRF!
Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.
© 2022 SENS Research Foundation – ALL RIGHTS RESERVED
